S&P 500   4,577.93 (+0.07%)
DOW   35,762.46 (+0.02%)
QQQ   380.09 (+0.26%)
AAPL   148.88 (-0.29%)
MSFT   319.83 (+3.13%)
FB   312.64 (-1.00%)
GOOGL   2,852.19 (+2.37%)
TSLA   1,051.78 (+3.27%)
AMZN   3,383.15 (+0.21%)
NVDA   245.72 (-0.59%)
BABA   170.82 (+0.49%)
NIO   40.66 (+0.47%)
CGC   13.26 (+0.68%)
GE   106.04 (-1.30%)
AMD   122.98 (+0.04%)
MU   67.58 (-1.97%)
T   25.34 (-0.12%)
F   15.76 (-1.13%)
ACB   7.08 (+0.71%)
DIS   170.85 (-0.69%)
PFE   43.06 (-1.15%)
BA   209.03 (-0.37%)
AMC   35.76 (-0.80%)
S&P 500   4,577.93 (+0.07%)
DOW   35,762.46 (+0.02%)
QQQ   380.09 (+0.26%)
AAPL   148.88 (-0.29%)
MSFT   319.83 (+3.13%)
FB   312.64 (-1.00%)
GOOGL   2,852.19 (+2.37%)
TSLA   1,051.78 (+3.27%)
AMZN   3,383.15 (+0.21%)
NVDA   245.72 (-0.59%)
BABA   170.82 (+0.49%)
NIO   40.66 (+0.47%)
CGC   13.26 (+0.68%)
GE   106.04 (-1.30%)
AMD   122.98 (+0.04%)
MU   67.58 (-1.97%)
T   25.34 (-0.12%)
F   15.76 (-1.13%)
ACB   7.08 (+0.71%)
DIS   170.85 (-0.69%)
PFE   43.06 (-1.15%)
BA   209.03 (-0.37%)
AMC   35.76 (-0.80%)
S&P 500   4,577.93 (+0.07%)
DOW   35,762.46 (+0.02%)
QQQ   380.09 (+0.26%)
AAPL   148.88 (-0.29%)
MSFT   319.83 (+3.13%)
FB   312.64 (-1.00%)
GOOGL   2,852.19 (+2.37%)
TSLA   1,051.78 (+3.27%)
AMZN   3,383.15 (+0.21%)
NVDA   245.72 (-0.59%)
BABA   170.82 (+0.49%)
NIO   40.66 (+0.47%)
CGC   13.26 (+0.68%)
GE   106.04 (-1.30%)
AMD   122.98 (+0.04%)
MU   67.58 (-1.97%)
T   25.34 (-0.12%)
F   15.76 (-1.13%)
ACB   7.08 (+0.71%)
DIS   170.85 (-0.69%)
PFE   43.06 (-1.15%)
BA   209.03 (-0.37%)
AMC   35.76 (-0.80%)
S&P 500   4,577.93 (+0.07%)
DOW   35,762.46 (+0.02%)
QQQ   380.09 (+0.26%)
AAPL   148.88 (-0.29%)
MSFT   319.83 (+3.13%)
FB   312.64 (-1.00%)
GOOGL   2,852.19 (+2.37%)
TSLA   1,051.78 (+3.27%)
AMZN   3,383.15 (+0.21%)
NVDA   245.72 (-0.59%)
BABA   170.82 (+0.49%)
NIO   40.66 (+0.47%)
CGC   13.26 (+0.68%)
GE   106.04 (-1.30%)
AMD   122.98 (+0.04%)
MU   67.58 (-1.97%)
T   25.34 (-0.12%)
F   15.76 (-1.13%)
ACB   7.08 (+0.71%)
DIS   170.85 (-0.69%)
PFE   43.06 (-1.15%)
BA   209.03 (-0.37%)
AMC   35.76 (-0.80%)
NASDAQ:SPNS

Sapiens International Stock Forecast, Price & News

$34.36
0.00 (0.00 %)
(As of 10/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.35
$34.40
50-Day Range
$27.59
$33.47
52-Week Range
$24.30
$35.85
Volume105 shs
Average Volume124,211 shs
Market Capitalization$1.88 billion
P/E Ratio49.09
Dividend Yield0.81%
Beta1.39
30 days | 90 days | 365 days | Advanced Chart
Receive SPNS News and Ratings via Email

Sign-up to receive the latest news and ratings for Sapiens International and its competitors with MarketBeat's FREE daily newsletter.


Sapiens International logo

About Sapiens International

Sapiens International Corp. NV provides software solutions for the insurance industry. It offers core, end-to-end solutions to the global general insurance, property and casualty, life, pension and annuities, reinsurance and retirement markets, as well as business decision management software. The company was founded by Joseph Bolless and Ron Zuckerman in 1982 and is headquartered in Holon, Israel.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
Application Software
Current Symbol
NASDAQ:SPNS
CUSIP
N7716A15
Employees
3,438
Year Founded
N/A

Sales & Book Value

Annual Sales
$382.90 million
Cash Flow
$1.60 per share
Book Value
$7.02 per share

Profitability

Net Income
$33.78 million

Debt

Price-To-Earnings

Miscellaneous

Market Cap
$1.88 billion
Next Earnings Date
11/3/2021 (Confirmed)
Optionable
Optionable

MarketRank

Overall MarketRank

1.85 out of 5 stars

Computer And Technology Sector

510th out of 869 stocks

Prepackaged Software Industry

150th out of 259 stocks

Analyst Opinion: 1.1Community Rank: 4.4Dividend Strength: 1.7Insider Behavior: 0.8Valuation: 1.3 5 -4 -3 -2 -1 -












Sapiens International (NASDAQ:SPNS) Frequently Asked Questions

Is Sapiens International a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sapiens International in the last year. There are currently 1 sell rating, 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Sapiens International stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SPNS, but not buy additional shares or sell existing shares.
View analyst ratings for Sapiens International
or view top-rated stocks.

What stocks does MarketBeat like better than Sapiens International?

Wall Street analysts have given Sapiens International a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sapiens International wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sapiens International?

Sapiens International saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 481,800 shares, a drop of 23.4% from the August 31st total of 629,000 shares. Based on an average trading volume of 106,600 shares, the short-interest ratio is presently 4.5 days. Currently, 1.6% of the shares of the stock are sold short.
View Sapiens International's Short Interest
.

When is Sapiens International's next earnings date?

Sapiens International is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Sapiens International
.

How can I listen to Sapiens International's earnings call?

Sapiens International will be holding an earnings conference call on Wednesday, November 3rd at 9:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Sapiens International's earnings last quarter?

Sapiens International Co. (NASDAQ:SPNS) announced its earnings results on Tuesday, August, 3rd. The technology company reported $0.29 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.26 by $0.03. The technology company earned $115 million during the quarter, compared to analysts' expectations of $112.50 million. Sapiens International had a trailing twelve-month return on equity of 15.60% and a net margin of 8.95%. Sapiens International's quarterly revenue was up 23.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.26 EPS.
View Sapiens International's earnings history
.

How has Sapiens International's stock been impacted by COVID-19 (Coronavirus)?

Sapiens International's stock was trading at $18.39 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SPNS stock has increased by 86.8% and is now trading at $34.36.
View which stocks have been most impacted by COVID-19
.

How often does Sapiens International pay dividends? What is the dividend yield for Sapiens International?

Sapiens International declared a -- dividend on Tuesday, April 13th. Shareholders of record on Tuesday, April 27th will be paid a dividend of $0.37 per share on Tuesday, May 11th. This represents a yield of 1.1%. The ex-dividend date of this dividend is Monday, April 26th.
View Sapiens International's dividend history
.

Is Sapiens International a good dividend stock?

Sapiens International pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.81%. Sapiens International does not yet have a strong track record of dividend growth. The dividend payout ratio of Sapiens International is 29.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Sapiens International will have a dividend payout ratio of 23.14% next year. This indicates that Sapiens International will be able to sustain or increase its dividend.
View Sapiens International's dividend history.

What guidance has Sapiens International issued on next quarter's earnings?

Sapiens International issued an update on its FY 2021 earnings guidance on Wednesday, August, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $461 million-$466 million, compared to the consensus revenue estimate of $461.53 million.

What price target have analysts set for SPNS?

4 Wall Street analysts have issued 1-year price objectives for Sapiens International's shares. Their forecasts range from $27.00 to $39.00. On average, they anticipate Sapiens International's stock price to reach $33.50 in the next twelve months. This suggests that the stock has a possible downside of 2.5%.
View analysts' price targets for Sapiens International
or view top-rated stocks among Wall Street analysts.

Who are Sapiens International's key executives?

Sapiens International's management team includes the following people:
  • Roni Al-Dor, President, Chief Executive Officer & Director
  • Roni Giladi, Chief Financial Officer
  • Ben Shory, Corporate Chief Technology Officer
  • Daphna Golden, Vice President & Head-Investor Relations
  • Tamar Alon-Verber, Chief Business Finance Officer

What is Roni Al-Dor's approval rating as Sapiens International's CEO?

152 employees have rated Sapiens International CEO Roni Al-Dor on Glassdoor.com. Roni Al-Dor has an approval rating of 83% among Sapiens International's employees.

What other stocks do shareholders of Sapiens International own?

What is Sapiens International's stock symbol?

Sapiens International trades on the NASDAQ under the ticker symbol "SPNS."

Who are Sapiens International's major shareholders?

Sapiens International's stock is owned by a variety of institutional and retail investors. Top institutional investors include Phoenix Holdings Ltd. (2.67%), Harel Insurance Investments & Financial Services Ltd. (1.11%), Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management (0.32%), Assenagon Asset Management S.A. (0.20%) and Ritholtz Wealth Management (0.01%).

Which institutional investors are selling Sapiens International stock?

SPNS stock was sold by a variety of institutional investors in the last quarter, including Ritholtz Wealth Management.

Which institutional investors are buying Sapiens International stock?

SPNS stock was acquired by a variety of institutional investors in the last quarter, including Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management , Phoenix Holdings Ltd., Assenagon Asset Management S.A., and Harel Insurance Investments & Financial Services Ltd..

How do I buy shares of Sapiens International?

Shares of SPNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sapiens International's stock price today?

One share of SPNS stock can currently be purchased for approximately $34.36.

How much money does Sapiens International make?

Sapiens International has a market capitalization of $1.88 billion and generates $382.90 million in revenue each year. The technology company earns $33.78 million in net income (profit) each year or $0.94 on an earnings per share basis.

How many employees does Sapiens International have?

Sapiens International employs 3,438 workers across the globe.

What is Sapiens International's official website?

The official website for Sapiens International is www.sapiens.com.

Where are Sapiens International's headquarters?

Sapiens International is headquartered at Azrieli Center 26 Harukmim St., Holon L3, 5885800.

How can I contact Sapiens International?

Sapiens International's mailing address is Azrieli Center 26 Harukmim St., Holon L3, 5885800. The technology company can be reached via phone at (723) 790-2000 or via email at [email protected].


This page was last updated on 10/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.